Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Motor Activity 2Weight Loss 1Small Cell Lung Carcinoma 1Sarcopenia 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Malnutrition 1Lung Neoplasms 1Heart Failure 1Esophageal Neoplasms 1Digestive System Carcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Tamoxifen 3Radiotherapy 3Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Radiation 2Observation 2Metformin 2pembrolizumab 1exemestane 1afimoxifene 1Tablets 1Surgical Procedures, Operative 1Steroids 1Specimen Handling 1Protons 1Proton Therapy 1Petrolatum 1Nutrition Assessment 1Neoadjuvant Therapy 1Mastectomy, Segmental 1Mammography 1Magnetic Resonance Spectroscopy 1Letrozole 1Biopsy, Needle 1Biopsy, Large-Core Needle 1Anastrozole 14,17 beta-dihydroxy-4-androstene-3-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Intraductal, Noninfiltrating × Nutrition Assessment × Clear all
NCT05023967 2026-01-05

Metformin and Nightly Fasting in Women With Early Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
120 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡